Insider Transactions in Q3 2024 at Viridian Therapeutics, Inc.\De (VRDN)

VRDN Quotes by TradingView

Insider Transaction List (Q3 2024)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Sep 27 2024
Stephen F. Mahoney President and CEO
BUY
Open market or private purchase
Direct
21,400 +50.0%
$492,200 $23.33 P/Share
Sep 27 2024
Thomas W. Beetham Chief Operating Officer
BUY
Open market or private purchase
Direct
5,000 +45.45%
$115,000 $23.41 P/Share
Sep 13 2024
Fairmount Funds Management LLC Director
BUY
Open market or private purchase
Indirect
1,600,000 +31.71%
$28,800,000 $18.75 P/Share

Track Institutional and Insider Activities on VRDN

Follow Viridian Therapeutics, Inc.\DE and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRDN shares.

Notify only if

Insider Trading

Get notified when an Viridian Therapeutics, Inc.\De insider buys or sells VRDN shares.

Notify only if

News

Receive news related to Viridian Therapeutics, Inc.\DE

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VRDN